Connect with us

Health

Prevalence, determinants, and outcomes of SARS‐COV‐2 infection among cancer patients. A population‐based study in northern Italy – Wiley

SARS-CoV-2 infection risk among cancer patients as compared to cancer-free individuals has been poorly investigated on a population-basis….

Published

on

Article feature image

1 INTRODUCTION
Biologic (e.g., immune depression related to anticancer treatments) and non-biologic factors (e.g., most people with cancer needs to interface with health institutions) have been hypothesized to expose cancer patients at higher risk of severe…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending